Plasma sRAGE is independently associated with increased mortality in ARDS: a meta-analysis of individual patient data

Intensive Care Medicine

Volumn 44, Issue 9, 2018, Pages 1388-1399

  Jabaudon, Matthieu ^a,b   Blondonnet, Raiko ^a,b   Pereira, Bruno ^a   Cartin Ceba, Rodrigo ^c   Lichtenstern, Christoph ^d   Mauri, Tommaso ^e   Determann, Rogier M ^f   Drabek, Tomas ^g   Hubmayr, Rolf D ^c   Gajic, Ognjen ^c   Uhle, Florian ^d   Coppadoro, Andrea ^h   Pesenti, Antonio ^e   Schultz, Marcus J ^i,j   Ranieri, Marco V ^k   Brodska, Helena ^l   Mrozek, Ségolène ^m   Sapin, Vincent ^a,b   Matthay, Michael A ⁿ   Constantin, Jean Michel ^a,b   Calfee, Carolyn S ⁿ   more..

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c MAYO CLINIC   (United States)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e UNIVERSITY OF MILAN   (Italy)

^f ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h SAN GERARDO HOSPITAL   (Italy)

ⁱ UNIVERSITY OF AMSTERDAM   (Netherlands)

^j MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^k MOLINETTE HOSPITAL   (Italy)

^l CHARLES UNIVERSITY   (Czech Republic)

^m TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Acute respiratory distress syndrome; Biomarker; Lung epithelial injury; Prognosis; Receptor for advanced glycation end products

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BIOLOGICAL MARKER;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL OUTCOME; FEMALE; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG EPITHELIUM; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; PROGNOSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIDAL VOLUME; APACHE; BLOOD; META ANALYSIS; METABOLISM; PHYSIOLOGY; RISK FACTOR; WORK OF BREATHING;

APACHE; BIOMARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; TIDAL VOLUME; WORK OF BREATHING;

EID: 85050717428     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-018-5327-1     Document Type: Article

References (49)

1. Definition Task Force ARDS, Ranieri VM, Rubenfeld GD et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307:2526–2533
2. Bellani G, Laffey JG, Pham T et al (2016) Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA 315:788–800
3. Matthay MA, Zimmerman GA, Esmon C et al (2003) Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 167:1027–1035
4. Matthay MA, Wiener-Kronish JP (1990) Intact epithelial barrier function is critical for the resolution of alveolar edema in humans. Am Rev Respir Dis 142:1250–1257
5. Matthay MA (2014) Resolution of pulmonary edema. Thirty years of progress. Am J Respir Crit Care Med 189:1301–1308
6. Uchida T, Shirasawa M, Ware LB et al (2006) Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury. Am J Respir Crit Care Med 173:1008–1015
7. Calfee CS, Ware LB, Eisner MD et al (2008) Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury. Thorax 63:1083–1089
8. Jabaudon M, Blondonnet R, Roszyk L et al (2015) Soluble receptor for advanced glycation end-products predicts impaired alveolar fluid clearance in acute respiratory distress syndrome. Am J Respir Crit Care Med 192:191–199
9. Bierhaus A, Humpert PM, Morcos M et al (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83:876–886
10. Ray P, Le Manach Y, Riou B, Houle TT (2010) Statistical evaluation of a biomarker. Anesthesiology 112:1023–1040
11. Jabaudon M, Futier E, Roszyk L et al (2011) Soluble form of the receptor for advanced glycation end products is a marker of acute lung injury but not of severe sepsis in critically ill patients. Crit Care Med 39:480–488
12. Jabaudon M, Blondonnet R, Roszyk L et al (2015) Soluble forms and ligands of the receptor for advanced glycation end-products in patients with acute respiratory distress syndrome: an observational prospective study. PLoS One 10:e0135857
13. Calfee CS, Budev MM, Matthay MA et al (2007) Plasma receptor for advanced glycation end-products predicts duration of ICU stay and mechanical ventilation in patients after lung transplantation. J Heart Lung Transpl 26:675–680
14. Mrozek S, Jabaudon M, Jaber S et al (2016) Elevated plasma levels of sRAGE are associated with nonfocal CT-based lung imaging in patients with ARDS: a prospective multicenter study. Chest 150:998–1007
15. Jabaudon M, Hamroun N, Roszyk L et al (2015) Effects of a recruitment maneuver on plasma levels of soluble RAGE in patients with diffuse acute respiratory distress syndrome: a prospective randomized crossover study. Intensive Care Med 41:846–855
16. Jabaudon M, Blondonnet R, Lutz J et al (2016) Net alveolar fluid clearance is associated with lung morphology phenotypes in acute respiratory distress syndrome. Anaesth Crit Care Pain Med 35:81–86
17. Gattinoni L, Pesenti A (2005) The concept of “baby lung”. Intensive Care Med 31:776–784
18. Amato MBP, Meade MO, Slutsky AS et al (2015) Driving pressure and survival in the acute respiratory distress syndrome. N Engl J Med 372:747–755
19. Samary CS, Santos RS, Santos CL et al (2015) Biological impact of transpulmonary driving pressure in experimental acute respiratory distress syndrome. Anesthesiology 123:423–433
20. Imai K, Keele L, Tingley D, Yamamoto T (2011) Unpacking the black box of causality: learning about causal mechanisms from experimental and observational studies. Am Polit Sci Rev 105:765–789
21. Stewart LA, Clarke M, Rovers M et al (2015) Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMA-IPD Statement. JAMA 313:1657–1665
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829
23. Knaus WA, Wagner DP, Draper EA et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100:1619–1636
24. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. on behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710
25. O’Brien PC (1984) Procedures for comparing samples with multiple endpoints. Biometrics 40:1079–1087
26. Harrell FE Jr, Lee KL, Mark DB (1996) Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15:361–387
27. Malek MH, Berger DE, Coburn JW (2007) On the inappropriateness of stepwise regression analysis for model building and testing. Eur J Appl Physiol 101:263–264 (author reply 265–6)
28. Shrout PE, Bolger N (2002) Mediation in experimental and nonexperimental studies: new procedures and recommendations. Psychol Methods 7:422–445
29. Cartin-Ceba R, Hubmayr RD, Qin R et al (2015) Predictive value of plasma biomarkers for mortality and organ failure development in patients with acute respiratory distress syndrome. J Crit Care 30(219):e1–e7
30. Brodska H, Malickova K, Valenta J et al (2013) Soluble receptor for advanced glycation end products predicts 28-day mortality in critically ill patients with sepsis. Scand J Clin Lab Invest 73:650–660
31. Mauri T, Masson S, Pradella A et al (2010) Elevated plasma and alveolar levels of soluble receptor for advanced glycation end products are associated with severity of lung dysfunction in ARDS patients. Tohoku J Exp Med 222:105–112
32. Determann RM, Royakkers AANM, Haitsma JJ et al (2010) Plasma levels of surfactant protein D and KL-6 for evaluation of lung injury in critically ill mechanically ventilated patients. BMC Pulm Med 10:6
33. Krull JL, MacKinnon DP (2001) Multilevel modeling of individual and group level mediated effects. Multivar Behav Res 36:249–277
34. Guérin C, Papazian L, Reignier J et al (2016) Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials. Crit Care 20:384
35. Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators, Cavalcanti AB, Suzumura ÉA et al (2017) Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs Low PEEP on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA 318:1335–1345
36. Neto AS, Hemmes SNT, Barbas CSV et al (2016) Association between driving pressure and development of postoperative pulmonary complications in patients undergoing mechanical ventilation for general anaesthesia: a meta-analysis of individual patient data. Lancet Respir Med 4:272–280
37. Calfee CS, Delucchi K, Parsons PE et al (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2:611–620
38. Famous KR, Delucchi K, Ware LB et al (2017) Acute respiratory distress syndrome subphenotypes respond differently to randomized fluid management strategy. Am J Respir Crit Care Med 195:331–338
39. Shirasawa M, Fujiwara N, Hirabayashi S et al (2004) Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9:165–174
40. Ware LB, Matthay MA (2000) The acute respiratory distress syndrome. N Engl J Med 342:1334–1349
41. Ware LB, Matthay MA (2001) Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 163:1376–1383
42. Briot R, Frank JA, Uchida T et al (2009) Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs. Chest 135:269–275
43. Calfee CS, Janz DR, Bernard GR et al (2015) Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies. Chest 147:1539–1548
44. Parsons PE, Eisner MD, Thompson BT et al (2005) Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 33:1–6 (discussion 230–2)
45. Guo WA, Knight PR, Raghavendran K (2012) The receptor for advanced glycation end products and acute lung injury/acute respiratory distress syndrome. Intensive Care Med 38:1588–1598
46. Mukherjee TK, Mukhopadhyay S, Hoidal JR (2008) Implication of receptor for advanced glycation end product (RAGE) in pulmonary health and pathophysiology. Respir Physiol Neurobiol 162:210–215
47. Dreyfuss D, Soler P, Basset G, Saumon G (1988) High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137:1159–1164
48. Tschumperlin DJ, Oswari J, Margulies AS (2000) Deformation-induced injury of alveolar epithelial cells. Effect of frequency, duration, and amplitude. Am J Respir Crit Care Med 162:357–362
49. Nuckton TJ, Alonso JA, Kallet RH et al (2002) Pulmonary dead-space fraction as a risk factor for death in the acute respiratory distress syndrome. N Engl J Med 346:1281–1286